Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$62.68 - $95.05 $12,724 - $19,295
203 New
203 $19,000
Q4 2022

Feb 07, 2023

SELL
$30.35 - $53.15 $227,412 - $398,252
-7,493 Reduced 77.67%
2,154 $106,000
Q3 2022

Oct 25, 2022

BUY
$31.97 - $49.37 $114,292 - $176,497
3,575 Added 58.88%
9,647 $313,000
Q2 2022

Aug 04, 2022

BUY
$35.61 - $76.23 $191,296 - $409,507
5,372 Added 767.43%
6,072 $239,000
Q1 2022

Apr 14, 2022

SELL
$57.56 - $82.54 $287,051 - $411,626
-4,987 Reduced 87.69%
700 $48,000
Q4 2021

Jan 18, 2022

BUY
$72.5 - $100.68 $289,057 - $401,411
3,987 Added 234.53%
5,687 $442,000
Q3 2021

Oct 26, 2021

BUY
$90.24 - $124.05 $27,072 - $37,215
300 Added 21.43%
1,700 $162,000
Q2 2021

Jul 19, 2021

SELL
$93.66 - $139.27 $46,830 - $69,635
-500 Reduced 26.32%
1,400 $174,000
Q1 2021

Apr 26, 2021

SELL
$116.57 - $155.01 $663,749 - $882,626
-5,694 Reduced 74.98%
1,900 $250,000
Q4 2020

Jan 21, 2021

BUY
$99.61 - $142.12 $361,584 - $515,895
3,630 Added 91.57%
7,594 $1.01 Million
Q3 2020

Oct 27, 2020

SELL
$72.92 - $102.01 $175,008 - $244,824
-2,400 Reduced 37.71%
3,964 $404,000
Q2 2020

Jul 22, 2020

SELL
$55.75 - $92.75 $42,314 - $70,397
-759 Reduced 10.66%
6,364 $553,000
Q1 2020

May 07, 2020

BUY
$37.9 - $104.44 $14,970 - $41,253
395 Added 5.87%
7,123 $413,000
Q4 2019

Feb 06, 2020

BUY
$77.66 - $99.74 $497,800 - $639,333
6,410 Added 2015.72%
6,728 $622,000
Q3 2019

Oct 28, 2019

SELL
$90.37 - $122.49 $70,488 - $95,542
-780 Reduced 71.04%
318 $28,000
Q4 2018

Feb 05, 2019

SELL
$56.04 - $82.66 $293,537 - $432,973
-5,238 Reduced 82.67%
1,098 $69,000
Q1 2018

May 11, 2018

BUY
$39.82 - $57.53 $113,925 - $164,593
2,861 Added 82.33%
6,336 $255,000
Q4 2017

Jan 17, 2018

BUY
$46.49 - $60.51 $73,221 - $95,303
1,575 Added 82.89%
3,475 $182,000
Q3 2017

Oct 17, 2017

BUY
$37.05 - $47.12 $70,395 - $89,528
1,900
1,900 $89,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.